Still in 2021, another research group described the synthesis and evaluation of a series of nitrogen mustard analogs containing the 1,3,5-triazine scaffold and dipeptide residues, and evaluated them as potential inhibitors of both AChE and BACE-1, two of the main hallmarks of AD (30, Figure 13) [53]. The gene discussed is BACE1; the disease is Alzheimer disease.